Clinical trial

A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute…

NCT00186901 · St. Jude Children's Research Hospital, Other · Completed

Key facts

NCT number NCT00186901
Title A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors
Official title Diminished Bone Mineral Density in Survivors of Childhood Acute Lymphoblastic Leukemia (ALL): A Severity-Adapted Clinical Trial
Lead sponsor St. Jude Children's Research Hospital, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Leukemia, Lymphoblastic, Acute, Osteoporosis
Intervention type Drug, Other
Interventions Calcium carbonate (Tums), vitamin D, Placebo
Enrollment 429
Start date Jul 1, 2000
Primary completion Jun 1, 2009
Completion Sep 1, 2011
First posted Sep 16, 2005
Last update posted May 10, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies